The
Himalaya Herbal Healthcare, pioneers in herbal remedies have launched
Himplasia, an effective, safe and clinically proven solution for
BPH (Benign Prostatic Hyperplasia). BPH is which is known to affect
approximately 25% of men aged 40 years or over and almost one in
every three men over 65 years of age.
Announcing the launch of the new drug, Philipe
J Haydon, General Manager - Pharma Marketing said, "the current
treatment for BPH has a lot of limitations. A patient not only faces
the problem of non-compliance, escalating cost and side effects
in a drug therapy but also faces limitations of a surgical procedure
which includes hospitalization, blood transfusion, urinary tract
infection, urethral stricture and development of urinary incontinence.
Considering these facts, Himalaya has introduced Himplasia to provide
relief with no side effects and improve the quality of life at a
price, which was patient friendly. Himplasia was thus conceived
to address this need."
Significant
features of Himplasia
Himplasia has the combination of time-tested herbs like Tribulus
terrestris, Caesalpinia bonducella, Areca catechu, Asparagus racemosus
and Crataeva nurvala.
Himplasia acts by inhibiting the enzyme 5
alpha reductase that is responsible for the conversion of testosterone
and also possesses alpha-receptor blocking activity, thereby relieving
individuals with BPH from both irritative (urinary frequency, nocturia)
and obstructive (hesitancy, poor and intermittent flow, incontinence)
symptoms.
Himplasia also improves the peak flow rate
and significant reduction in the prostatic weight. All these factors
lead to an overall improvement in the individual's quality of life.
Himplasia is available in a strip of 30
tablets priced at Rs.3.00 per tablet and the recommended dosage
is 2 tablets a day.
About the
company
Since its inception in 1930, Himalaya has pioneered the use of modern
science to rediscover and validate ayurveda's secrets. Today, Himalaya
products serve the health and personal care needs of consumers in
over 55 countries including USA, UK, Holland, Switzerland and Belgium.
All formulations of Himalaya are subject
to primary research for upto 10 years before it reaches the consumer
as the final product. It is this emphasis on research and stringent
quality standards that has led 200,000 doctors worldwide to endorse
Himalaya products.
For more information, visit Himplasia page. |